Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acorda Therapeutics, Inc.
Acorda Therapeutics to Present an Overview of its Preclinical Pipeline at Windhover Therapeutic Area Partnerships Conference
November 21st, 2008
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Anthony Caggiano M.D., Ph.D., Senior Director, Preclinical Development, will present an overview of the Company's preclinical pipeline at the Windhover Therapeutic Area Partnerships Conference on Tuesday, November 4, 2008 at 3:50 p.m. ET at the Loews Philadelphia Hotel in Philadelphia, PA. The Acorda preclinical pipeline has been selected by Windhover Information as one of the top 10 most interesting neuroscience projects in development available for strategic partnering. Acorda's preclinical pipeline comprises three programs: a monoclonal antibody (rhIgM22), being studied in collaboration with...
Source: Health Business Week (2008-11-21)
|
